Cisatracurium Besylate 70436-0113
Product NDC
70436-0113- Manufacturer
- Slate Run Pharmaceuticals, Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 1, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA216538
Need to source Cisatracurium Besylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cisatracurium Besylate | 2 mg/mL |
Drug Class
Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]
Packaging Options(1)
10 VIAL, SINGLE-DOSE in 1 CARTON (70436-113-82) / 10 mL in 1 VIAL, SINGLE-DOSE